SCHEMBL9348292

SCHEMBL9348292

Cc1cnc(Nc2ccccc2)c(C(=O)O)n1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIM1 P11309 2/20 0.49
DHODH Q02127 1/20 0.46
GSK3B P49841 4/20 0.44
GSK3A P49840 3/20 0.44
PDE10A Q9Y233 1/20 0.43
EGFR P00533 2/20 0.43
ITK Q08881 1/20 0.43
GAA P10253 2/20 0.43
HCAR3 P49019 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
MAPK8 P45983 1/20 0.42
AURKA O14965 2/20 0.42
CCNA2 P20248 1/20 0.42
CDK2 P24941 1/20 0.42
PLK1 P53350 1/20 0.42
CCNA1 P78396 1/20 0.42
PDE4B Q07343 1/20 0.42
PDE4D Q08499 1/20 0.42
RAB9A P51151 2/20 0.41
KMT2A Q03164 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4129926 0.87 GRM5 (0.48) DHODHPDE10ARAB9ANPC1GRM5
SCHEMBL2160345 0.83 PDE10A (0.50) PDE10A
SCHEMBL3579095 0.78 GRM5 (0.38) GAAHCAR3SMN1; SMN2KMT2AMEN1
SCHEMBL4141530 0.77 HCAR2 (0.40) PIM1PDE10AEGFRGRM5
SCHEMBL4134533 0.75 DHODH (0.62) PIM1DHODHGSK3BGSK3AGAA
SCHEMBL4907684 0.74 GRM5 (0.49) PIM1PDE10AGAAHCAR3SMN1; SMN2
SCHEMBL12100927 0.72 BCL6 (0.49) GSK3BGSK3AEGFRITKGAA
SCHEMBL29806160 0.72 DHODH (0.44) PIM1DHODHGSK3BGSK3AEGFR
SCHEMBL22932198 0.72 DHODH (0.44) PIM1DHODHGSK3BGSK3AEGFR
SCHEMBL29432473 0.72 ALDH1A1 (0.41) SMN1; SMN2KMT2AMEN1GRM5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5350755-A Treatment of psoriasis or eczema with naphthyridine derivative SCHERING CORPORATION (US) 1994-09-27 US disclosed
EP-0127135-B1 FUSED TRICYCLIC DERIVATIVES OF NAPHTHYRIDINONE AND PYRIDONE AND THE CORRESPONDING THIONES SCHERING CORPORATION (US) 1990-08-29 EP disclosed
EP-0144996-B1 SUBSTITUTED SPIRO PYRIDINE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND PROCESSES FOR THE PREPARATION OF SUCH COMPOUNDS AND COMPOSITIONS SCHERING CORPORATION (US) 1990-02-28 EP disclosed
US-4775524-A PSORIASIS SCHERING CORPORATION (US) 1988-10-04 US disclosed
US-4740511-A ANTIALLERGENS, ANTIINFLAMMATORY, ANTIULCER AGENTS SCHERING CORPORATION (US) 1988-04-26 US disclosed
US-4680298-A Tricyclic anti-allergy and use as anti-inflammatory agents SCHERING CORPORATION (US) 1987-07-14 US disclosed
US-4680297-A Tricyclic positive inotropic agents SCHERING CORPORATION (US) 1987-07-14 US disclosed
US-4652564-A Substituted spiro pyridine derivatives as anti-allergy and antiinflammatory agents SCHERING CORPORATION (US) 1987-03-24 US disclosed
EP-0092786-B1 1,8-NAPHTHYRIDINE AND 1,5,8-AZANAPHTHYRIDINE DERIVATIVES SCHERING CORPORATION (US) 1987-01-07 EP disclosed
US-4632923-A Substituted hetero spiro pyridine derivatives as anti-allergy and anti-inflammatory agents SCHERING CORPORATION (US) 1986-12-30 US disclosed
EP-0127135-A2 Fused tricyclic derivatives of naphthyridinone and pyridone and the corresponding thiones SCHERING CORPORATION (US) 1984-12-05 EP disclosed
EP-0092786-A2 1,8-Naphthyridine and 1,5,8-azanaphthyridine derivatives SCHERING CORPORATION (US) 1983-11-02 EP disclosed